Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board

What are you looking for?

  • Anterior Segment
  • Cataract
  • Cornea and External Disease
  • Diabetic Macular Edema
  • Dry Eye
  • Early Onset Cataracts
  • Exclusives
  • General
  • Geographic Atrophy
  • Glaucoma
  • Industry News
  • Inherited Retinal Disease
  • IOLs
  • Neurotrophic Keratitis
  • Ocular Surface Disease
  • Oculoplastics
  • Optometry
  • Pediatrics
  • Practice Management
  • Presbyopia
  • Refractive Surgery/Vision Correction
  • Residents & Young Ophthalmologists
  • Retina
  • Retina Care 360
  • Retinopathy of Prematurity
  • Spotlight Series
  • The Interventional Glaucoma Project
  • The Ophthalmic Project
  • Trending Topics
Spotlight - The Future of Cryopreserved Amniotic Membrane in Oculoplastic Surgery
Optometry360 Logo White
  • Conferences
  • Videos
  • Podcasts
  • Quizzes
  • About
    • About Us – Mission
    • Content Awards
    • Media Partners
    • Business Team
    • Brand Ambassadors
    • Industry Council
    • Advisory Board
Home > Dry Eye > Survey highlights gaps in dry eye disease management among cataract surgeons
  • Dry Eye

Survey highlights gaps in dry eye disease management among cataract surgeons

Kelsey Moroz

Although most clinicians recognize the impact of cataract surgery on dry eye disease (DED), there are significant gaps in routine preoperative assessments and postoperative testing, according to a study.

A recent prospective face-to-face survey evaluated how clinicians manage DED in patients undergoing cataract surgery.

The survey included 127 participants, including ophthalmologists (39%), trainees and fellows (37%), and optometrists (8%), achieving a 100% response rate. Overall, 67% of respondents routinely assessed for DED before surgery, although 81% acknowledged that cataract surgery could have mild to moderate negative effects on DED.

Approximately 75% estimated that over 10% of pre-operative patients had asymptomatic DED, with over 10% experiencing symptomatic DED. Post-surgery, nearly 80% of clinicians believed that 10% or more of patients suffered from DED.

Although more DED tests were conducted preoperatively than postoperatively, ophthalmologists were more likely than others to perform these tests after surgery. Common management strategies included lubricating drops (95%), lid hygiene (75%), and night ointments or gels (54%). In addition, 76% of surgeons used ophthalmic visco-surgical devices, and 34% limited intra-operative light exposure to mitigate DED risks.

Reference
Naderi K, Maubon L, Jeffrey Lam CF, et al. A face-to-face survey on the practice of ophthalmic clinicians in the management of dry eye disease in patients undergoing cataract surgery. Eur J Ophthalmol. 2025;11206721241312249. doi: 10.1177/11206721241312249. Epub ahead of print. PMID: 39834340.

Share

Related Content

  • Dry Eye

Spotlight on LACRIFILL®

  • Conference Roundup

If your patient has recurrent chalazia, consider co-occurring Demodex blepharitis

  • Conference Roundup

Ocular staining and dry mouth may help identify Sjögren’s-related dry eye

  • Conference Roundup

Daily vaping associated with increased risk of ocular surface disease

  • Conference Roundup

Nearly half of eye care providers show Demodex infestation, with severity increasing over time in practice

  • Conference Roundup

Higher Demodex burden linked to reduced lipid layer thickness in blepharitis

Share

Editor's Picks

  • Neurotrophic Keratitis

Topical insulin shows real-world benefit in neurotrophic keratopathy

  • Retina

GLP-1 RAs have protective effects against AMD

  • Retina

Four-month injection intervals appear safe for long-term stable nAMD

Advisory Board

Saad Ahmad, MD

Ahmad A. Aref, MD, MBA

Roomasa Channa, MD

David Chow, MD, FRCS(C)

Sally L. Baxter, MD, MSc

Neel R. Desai, MD

Nadia Haqqie, MD

Simon Fung, MD, FRCOphth

Sumit Garg, MD

Ross Lakhanpal, MD, FACS

Sanjai Jalaj, MD

Anton Kolomeyer, MD, PhD

Shan Lin, MD

Steven R. Sarkisian, Jr., MD

See All
Optometry360 Logo

Ophthalmology 360® is a dynamic digital platform dedicated to advancing the field of eye care.

Get to Know Us

  • Home
  • About Us
  • Media Partners
  • Advertising Policy
  • Our Advisory Board

Sign up for our Newsletter

Sign up for our Newsletter to get our newest articles instantly!

  • Privacy Policy
  • Advertising Policy
  • Medical Disclaimer
IHM Logo

2026 Ophthalmology 360 is a trademark of International Healthcare Media, LLC. All rights reserved

  • MedJournal360 Icon
  • RareDisease360 Icon
  • MyHero360 Icon
  • Optometry360 Icon
  • Ophtalmology360 Icon